Organisation › Details

GlaxoSmithKline (GSK) (Group)

http://www.gsk.com

GlaxoSmithKline- one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. *

	Start	2000-12-27 merged
	Predecessor	Glaxo Wellcome (Group)
	Industry	pharmaceutical
	Industry 2	vaccine
	Person	Walmsley, Emma (GSK 201704– CEO before CEO of GSK Consumer Healthcare division joined GSK 2010 from L’Oréal)
	Person 2	Mackay, Iain (GSK 201901– CFO before HSBC + GE + Schlumberger Dowell + Price Waterhouse)

	Region	United Kingdom (town unspecified)
	Country	United Kingdom (GB)
	Street	980 Great West Road
	City	TW8 9GS Brentford, Middlesex
	Tel	+44-0-20-8047-5000
		Address record changed: 2008-12-07

Basic data	Employees	n. a.
	Currency	GBP
	Annual sales	22,716,000,000 (turnover, consolidated (2007) 2007-12-31)
	Profit	7,931,000,000 (2007-12-31)
	Cash	3,379,000,000 (2007-12-31)

		* Document for ï¿½About Sectionï¿½:

		Record changed: 2019-10-09

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

More documents for GlaxoSmithKline (GSK) (Group)

[1] Bavarian Nordic A/S. (11/13/19). "Press Release: Bavarian Nordic Announces Appointment of Jean-Christophe May as Executive Vice President and Chief Commercial Officer". Copenhagen....
[2] Bavarian Nordic A/S. (10/21/19). "Press Release: Bavarian Nordic Announces a Transformative Acquisition of Two Established Commercial Vaccines from GlaxoSmithKline". Copenhagen....
[3] GlaxoSmithKline plc. (10/8/19). "Press Release: GSK and Lyell Immunopharma Join Forces to Develop the Next Generation of Cancer Cell Therapies". London & San Francisco, CA....
[4] Cyclica Inc.. (10/8/19). "Press Release: To Build Stronger Partnerships Globally, Cyclica Appoints Long Time Pharma R&D Leader Vern De Biasi as VP, Global Head of Strategic Partnerships". Toronto....
[5] Avalon Ventures. (9/11/19). "Press Release: Avalon Ventures and COI Pharmaceuticals Announce Acquisition of Sitari Pharmaceuticals by GSK". San Diego, CA....
[6] GlaxoSmithKline plc. (8/23/19). "Press Release: GSK Announces Positive Headline Results from the Pivotal DREAMM-2 Study for Multiple MMyeloma". London....
[7] GlaxoSmithKline plc. (8/22/19). "Press Release: ViiV Healthcare Reports Positive Phase III Study Results of Investigational, Long-acting, Injectable HIV-treatment Regimen Administered every Two Months". London....
[8] GlaxoSmithKline plc. (8/21/19). "Press Release: GSK Submits First Regulatory Application for Daprodustat in Japan for Patients with Renal Anaemia Due to Chronic Kidney Disease". London....
[9] GlaxoSmithKline plc. (8/12/19). "Press Release: GSK Announces Leadership Changes in the US". Philadeliphia, PA....
[10] MorphoSys AG. (7/3/19). "Press Release: MorphoSys' Licensing Partner GSK Initiates Phase 3 Clinical Program With Otilimab (MOR103/GSK3196165) in Rheumatoid Arthritis; MorphoSys Updates its Financial Guidance for 2019". Planegg....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]